Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk

Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk

Background and aims Liver steatosis and fibrosis increase the predicted 10-year atherosclerotic cardiovascular disease (ASCVD) risk, though the roles of chronic inflammation and metabolic dysregulation remain unclear. This cross-sectional study quantitatively assesses this association and evaluates...

Full description

Saved in:
Bibliographic Details
Main Authors: Zihao Gui, Xingying Chen, Dongmei Wang, Zhi Chen, Siyang Liu, Genfeng Yu, Yuqi Jiang, Hualin Duan, Daoyan Pan, Xu Lin, Lan Liu, Heng Wan, Jie Shen
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Annals of Medicine
Subjects:
ASCVD
CAP
LSM
MASLD
hs-CRP
HOMA-IR
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2025.2486594
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items